Diantha Duvall
Director of Finance/CFO at CURIS, INC.
Net worth: 9 351 $ as of 2024-04-29
Active connections
Name | Gender | Age | Linked companies | Collaboration |
---|---|---|---|---|
James Dentzer | M | 57 | 8 years | |
David I. Stirling | M | - |
BioTheryX, Inc.
BioTheryX, Inc. Pharmaceuticals: MajorHealth Technology BioTheryX, Inc. pengages in the development of clinical drugs. It focuses on the restoration of protein homeostasis, including protein degradation and modulation, and multi-kinase inhibition. The company was founded by David I. Stirling and Lawrence Zaslow in 2007 and is headquartered in Chappaqua, NY. | 17 years |
Robert Davis | M | 57 | 10 years | |
John Hohneker | M | 64 |
BioTheryX, Inc.
BioTheryX, Inc. Pharmaceuticals: MajorHealth Technology BioTheryX, Inc. pengages in the development of clinical drugs. It focuses on the restoration of protein homeostasis, including protein degradation and modulation, and multi-kinase inhibition. The company was founded by David I. Stirling and Lawrence Zaslow in 2007 and is headquartered in Chappaqua, NY. | 3 years |
Robert Martell | M | 61 | 13 years | |
Nancy Miller-Rich | F | 65 |
BioTheryX, Inc.
BioTheryX, Inc. Pharmaceuticals: MajorHealth Technology BioTheryX, Inc. pengages in the development of clinical drugs. It focuses on the restoration of protein homeostasis, including protein degradation and modulation, and multi-kinase inhibition. The company was founded by David I. Stirling and Lawrence Zaslow in 2007 and is headquartered in Chappaqua, NY. | 8 years |
Martyn Greenacre | M | 82 | 24 years | |
Philippe Drouet | M | - |
BioTheryX, Inc.
BioTheryX, Inc. Pharmaceuticals: MajorHealth Technology BioTheryX, Inc. pengages in the development of clinical drugs. It focuses on the restoration of protein homeostasis, including protein degradation and modulation, and multi-kinase inhibition. The company was founded by David I. Stirling and Lawrence Zaslow in 2007 and is headquartered in Chappaqua, NY. | 3 years |
Mark W. Noel | M | 65 | 23 years | |
William Sibold | M | - | 6 years | |
Anne Borgman | M | 56 | 2 years | |
Chirfi Guindo | M | 58 | 13 years | |
Timothy Harris | M | 74 | 9 years | |
Marc Rubin | M | 69 | 14 years | |
Dalton Smart | M | 58 | 15 years | |
Kenneth Kaitin | M | 71 | 21 years | |
Reinhard von Roemeling | M | - | 5 years | |
Kimberly Steinmann | M | - | 2 years | |
Dora Ferrari | F | - | 3 years | |
Carol Bowden | F | - | 10 years | |
Nancy Soohoo | F | - | 21 years | |
Andre Musto | M | - | 10 years | |
Allan Gabor | M | - | 11 years | |
Robert Michael Platek | M | - |
BioTheryX, Inc.
BioTheryX, Inc. Pharmaceuticals: MajorHealth Technology BioTheryX, Inc. pengages in the development of clinical drugs. It focuses on the restoration of protein homeostasis, including protein degradation and modulation, and multi-kinase inhibition. The company was founded by David I. Stirling and Lawrence Zaslow in 2007 and is headquartered in Chappaqua, NY. | 4 years |
Denise Williams | F | - | 15 years | |
Jonathan Zung | M | 59 | 1 years | |
Philippe Sauvage | M | - | 6 years | |
Sanat Chattopadhyay | M | - | 15 years | |
Kyle W. H. Chan | M | - |
BioTheryX, Inc.
BioTheryX, Inc. Pharmaceuticals: MajorHealth Technology BioTheryX, Inc. pengages in the development of clinical drugs. It focuses on the restoration of protein homeostasis, including protein degradation and modulation, and multi-kinase inhibition. The company was founded by David I. Stirling and Lawrence Zaslow in 2007 and is headquartered in Chappaqua, NY. | 17 years |
Richard DeLuca | M | 61 | 13 years | |
Louis J. DeGennaro | M | - |
BioTheryX, Inc.
BioTheryX, Inc. Pharmaceuticals: MajorHealth Technology BioTheryX, Inc. pengages in the development of clinical drugs. It focuses on the restoration of protein homeostasis, including protein degradation and modulation, and multi-kinase inhibition. The company was founded by David I. Stirling and Lawrence Zaslow in 2007 and is headquartered in Chappaqua, NY. | - |
Rajeev Dadoo | M | 54 |
BioTheryX, Inc.
BioTheryX, Inc. Pharmaceuticals: MajorHealth Technology BioTheryX, Inc. pengages in the development of clinical drugs. It focuses on the restoration of protein homeostasis, including protein degradation and modulation, and multi-kinase inhibition. The company was founded by David I. Stirling and Lawrence Zaslow in 2007 and is headquartered in Chappaqua, NY. | - |
Peter N. Crnkovich | M | - |
BioTheryX, Inc.
BioTheryX, Inc. Pharmaceuticals: MajorHealth Technology BioTheryX, Inc. pengages in the development of clinical drugs. It focuses on the restoration of protein homeostasis, including protein degradation and modulation, and multi-kinase inhibition. The company was founded by David I. Stirling and Lawrence Zaslow in 2007 and is headquartered in Chappaqua, NY. | 5 years |
Jeffrey Edwards | M | 64 |
BioTheryX, Inc.
BioTheryX, Inc. Pharmaceuticals: MajorHealth Technology BioTheryX, Inc. pengages in the development of clinical drugs. It focuses on the restoration of protein homeostasis, including protein degradation and modulation, and multi-kinase inhibition. The company was founded by David I. Stirling and Lawrence Zaslow in 2007 and is headquartered in Chappaqua, NY. | 5 years |
Rachel Blasbalg | F | - | 20 years |
Connections Chart
Multi-company connection
Former connections
Name | Gender | Age | Linked companies | Collaboration |
---|---|---|---|---|
William Steinkrauss | M | 39 | 6 years | |
John Cox | M | 61 | 15 years | |
Fred Hassan | M | 78 | 6 years | |
Richard Clark | M | 77 | 6 years | |
Michel Vounatsos | M | 62 | 6 years | |
Douglas Kerr | M | 57 | 2 years | |
Lori Kunkel | M | 66 | 6 years | |
Andrea DiFabio | F | 55 | 2 years | |
Richard Brudnick | M | 67 | 17 years | |
Larry G. Edwards | M | 52 | 15 years | |
Scott Dreyer | M | 52 | 22 years | |
Howard Mayer | M | 62 | 3 years | |
Jennifer Herron | F | 54 | - | |
Michael Nally | M | 48 | 10 years | |
Laura Sepp-Lorenzino | M | 63 | 15 years | |
Ali Behbahani | M | 47 | 4 years | |
Geno Germano | M | 63 | - | |
Ronald Cooper | M | 61 | 5 years | |
John Lunger | M | 55 | - | |
John Greene | M | 58 | 2 years | |
Jacquelyn Sumer | F | 46 | - | |
Julie Gerberding | M | 69 | - | |
Thomas Robert Cech | M | 76 | - | |
Thomas Shenk | M | 77 | 11 years | |
Harry R. Jacobson | M | 76 | 3 years | |
Gisela Schwab | M | 67 | 1 years | |
Steven Goldstone | M | 78 | 6 years | |
William N. Kelley | M | 84 | - | |
Robert Iannone | M | 57 | 6 years | |
Jean-Marie Canan | M | 68 | 5 years | |
Rupert Vessey | M | 59 | - | |
Robert Meyer | M | 65 | 6 years | |
Roger Perlmutter | M | 71 | 8 years | |
Yao Lee | M | 54 | 3 years | |
James Swanson | M | 58 | 8 years | |
Barry Gertz | M | 72 | 28 years | |
Jens Renstrup | M | 59 | 8 years | |
Maude Tessier | M | 46 | 6 years | |
Christine Cioffe | F | - | 20 years | |
Paul Daruwala | M | 55 | 18 years | |
Karen Ling | F | 60 | 6 years | |
Jacob Harel | M | 69 | 13 years | |
Jeffrey Berkowitz | M | 58 | 1 years | |
David Mauro | M | 59 | 7 years | |
John Kelly | M | 57 | 9 years | |
C. Nicholson | M | 68 | 2 years | |
Thomas J. Ouellette | M | - | 16 years | |
Richard Kender | M | 68 | 35 years | |
Allan I. Goldberg | M | - | - | |
Aaron Dent | M | - | 6 years | |
Eric Schadt | M | 59 | 8 years | |
Stijn Michiel Ehren | M | - | - | |
Kathleen Metters | M | 66 | 13 years | |
Sheela Mohan-Peterson | F | 61 | 5 years | |
Wei Tang | M | - | 15 years | |
Dawn Svoronos | F | 70 | 2 years | |
James F. Fuqua | M | - | 31 years | |
Eva Boratto | F | 57 | 2 years | |
Richard Murray | M | 65 | 5 years | |
Barry Goldstein | M | - | 5 years | |
Rita Karachun | F | 63 | 14 years | |
Yan Li | F | 50 | 4 years | |
Barbara Yanni | F | 69 | 13 years | |
Richard S. Shames | M | - | 4 years | |
Arnaub Chatterjee | M | - | 5 years |
Statistics
Country | Connections | % of total |
---|---|---|
United States | 100 | 100.00% |
Age of Connections
Active
Past
Male
Female
Members of the board
Executives
Origin of connections
- Stock Market
- Insiders
- Diantha Duvall
- Personal Network